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A (mtTFA) and indirect role via up-regulation of the p53R2
expression2-4. Recently more than 6 kinds of P53 isoform have
been reported and they played the different role in DNA repair
pathways, cell-cycle checkpoints and cell apoptosis5. P53 and its
different p53 isoforms play what kind of role in mitochondrial
toxicity induced by NRTIs is unclear. In this study, we identiﬁed
the role of wild type p53 and its isoforms (N40P53 and N133P53)
in mitochondrial toxicity induced by AZT and oxidative stress.
In this study we treated the A549 p53+/+, H1299 N40 P53+/+,
H1299 N133P53+/+ and H1299 P53-/- cell lines with 5 to 200
μM AZT for 12 hours for studying cell death and the expression
of p53R2, p21 and bax via p53R2 (Bax, P21) pGL3-Luciferase
reporter gene assay, real-time PCR and Western Blotting; treated
cells with 30uμM AZT for 5 weeks, 10 weeks and 1μM H2O2
for 1 hour/week to study the mtDNA mutation, mtDNA deletion
and mitochondrial toxicity. The cells were treated with p53R2
interference RNA to study the p53R2 how regulated the DNA Pol
γ capability.
The result showed that A549 p53+/+ cell death is more sensi-
tive to high concentration of AZT. The increased cell death was
detected from 120 uM of AZT and more that 80% cell were into
apaotosis in 2000 μM AZT. But other three cell lines have strong
tolerance to AZT toxicity. They are only less than 10% cell death
in 2000 μM AZT. The results from report gene assay and real-time
PCR assay suggested that wild type p53, N40 P53, N133P53 played
different role in p53R2, P21 and Bax promoters. All of wild type
and isoform P53 up-regulated the p53R2 expression, but isoform
P53 played a domain negative regulation in Bax expression. The
p21 expression was co-stimulated by wilde-type P53 and N40,
N133P53. D-loop of mtDNA mutation and mtDNA quatitiy assay
showed that A549 p53+/+ cell has lower mtDNA mutation rate
and almost no mtDNA loss following 5 weeks AZT stress. N40
P53,N133P53 cells have lower mtDNA mutation too, but mtDNA
loss is signiﬁcant higher than that in A549 P53 +/+ cells. H1299
P53 null cells has higher mtDNA mutation rate and mtDNA loss
than that in wild-type P53 and N40 P53, N133P53 isoform cells.
Conclusion: Both wild type and N40 P53,N133P53 isoform p53
play protect role in AZT induced mitochondrial toxicity. The
P53R2 would be involved in the centrol molecular pathway of p53
reduced mtDNA mutation and mtDNA loss induced by AZT
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Objective: To investigate the HIV incidence and the baseline
demographic data, clinical characteristics of acute HIV infec-
tions among self-identiﬁed men who have sex with men (MSM)
population in Beijing.
Methods: From May 2007 to February 2009, a hospital-based
cohort of HIV-uninfected MSM was established for a natural his-
tory study of HIV-1 infection. The cohort was followed every
two months to determine HIV incidence by pooling nucleic acid
testing (NAT) of third-generation enzyme immunoassay (EIA)-
negative samples.
Results: After screening 2861 individuals, a hospital-based co-
hort of 1529 uninfected high-risk MSM was established. During
1147.575 person-years of follow-up, 8424 samples were screened
for acute HIV infection by pooling nucleic acid testing (NAT)
of third-generation enzyme immunoassay (EIA)-negative sam-
ples (n =8221). HIV-prevalence at screening was 9.29% posing a
challenge in HIV-negative MSM. 63 infections occurred yielding
seroincidence rate of 5.49 per 100 person-years. 15 acute HIV-
infected subjects were identiﬁed by pooled NAT. Median HIV RNA
was 5.34 copies per milliliter (log10 viral load (VL) =220,000).
Conclusions: HIV prevalence in MSM population is signiﬁcantly
greater than that in the general population, which reﬂects the
current epidemic in Beijing and justiﬁes prevention programs
aimed at this group. This high-risk population may be suitable for
future studies on acute HIV infection, HIV treatment, vaccine,
and prevention of onward transmission strategies.
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Objectives: To study the features of liver injury in HIV-1-
infected patients receiving non-nucleosides reverse transcriptase
inhibitors-based antiretroviral therapy (ART).
Methods: 75 patients receiving non-nucleosides reverse tran-
scriptase inhibitors-based ART were retrospectively studied. The
patients were divided into 2 groups: liver injury group (n=45) and
non-liver injury group (n=30). The features of liver injury were
analysed. The prevelance of HBV and/or HCV, hepatotoxic drugs
use and NVP or EFV use were compared between two groups.
Results: 45 (60%) patients, 31 (68.9%) males and 14 (31.1%)
females, aged 12–52 years, averaged 39±9 years, experienced
at least one episode of liver injury. 40 (53.3%) co-infected with
HBV and/or HCV, 42 (56%) patients had concomitant use of an-
tituberculosis drugs, 46 (61.3%) and 29 (38.7%) received regimen
containing NVP or EFV, respectively. Grade 1 liver injury were
observed in 26 (34.7%) patients, grade 2 in 16 (21.3%), grade 3 in
2 (2.7%) and grade 4 in 1 (1.3%), respectikvely. 3 (4%) patients dis-
continued ART due to liver injury. There were 29 (64.4%) patients
coinfected with HBV and/or HCV, 32 (71.1%) received regimens
containing NVP, and 30 (66.7%) had concomitant use of antibu-
berculosis drugs in liver injury group, respectively, signiﬁcantly
higher than those in non-liver injury group [11 (36.7%), 14 (46.7%)
and 12 (40%), respectively. P=0.018, 0.033, 0.023, respectively].
Conclusions: Liver injury in HIV-1-infected patients receiving
non-nucleosides reverse transcriptase inhibitors-based antiretro-
viral therapy was mild to moderate, those who coinfeted with
HBV and/or HCV, had cocomitant use of antibuberculosis drugs
or cotrimoxazole and received a regimen containing NVP were
prone to liver injury.
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Introduction: Immune reconstitution syndrome, caused by
restoration of the capacity to mount an inﬂammatory response,
can lead to morbidity and mortality in HIV patients.
Case description: A 38 y/o presented with fever and weight loss.
HIV test was positive and blood culture grew Crytococcus Neofor-
mans. CD4 was 45 cells/ml and viral load (VL) 800,000 copies/ml.
Chest CT revealed hilar lymphadenopathy and RLL lesion. Few
weeks into treatment with Amphotericin B and subsequently Flu-
conazole, combination antiretroviral therapy (CART) was added
to PCP and MAC prophylaxis. After 4 weeks, he presented with
fever and cervical lymphadenopathy. CD4 was 322, VL 80,000.
Bronchial washing showed Cryptococcus and MAC. Amphotericin
B, Rifabutin, Ethambutol and Azithromycin were started. One
month later fever and lymphadenopathy continued. Biopsy of
a node showed necrotizing granuloma due to MAC. IRIS with
Disseminated MAC was diagnosed and considering progressive
